Table 2.
Prevalence of Antipsychotic Use and Percent of Exposed with At Least One Day of Potentially Excessive Dosing.a
| Agentb | Overall Prevalence n = 17,775 |
% of Exposed with Potentially Excessive Dosinga
|
||
|---|---|---|---|---|
| Within 100% of Recommended DDa | 101–150% of Recommended DDa | > 150% of Recommended DDa | ||
| Any Antipsychotic | 8.6 | 84.5 | 6.5 | 9.0 |
| Atypical | 7.2 | 87.6 | 5.3 | 7.1 |
| Quetiapine (200) | 3.3 | 87.3 | 5.5 | 7.2 |
| Olanzapine (10) | 3.3 | 88.7 | 5.6 | 5.7 |
| Risperidone (2) | 0.6 | 87.8 | 4.7 | 7.5 |
| Other | 0.7 | 95.4 | 0.0 | 4.6 |
| Typical | 2.8 | 79.4 | 9.3 | 11.3 |
| Haloperidol (4) | 2.4 | 79.6 | 9.1 | 11.2 |
| Chlorpromazine (75) | 0.3 | 80.0 | 9.1 | 10.9 |
| Other | 0.4 | 99.2 | 0.4 | 0.4 |
Abbreviations: DD = daily dose.
a
Defined by the Centers for Medicare and Medicaid Services (CMS) guidelines for long term care facilities
b
Numbers in parentheses represent the recommended daily dose above which use should be justified based on the CMS guidelines for long term care facilities